查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983698

靜脈穿刺市場：按設備類型、應用和最終用戶分類 - 2026-2032年全球市場預測

Venipuncture Procedure Market by Device Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈穿刺市場價值將達到 13.7 億美元，到 2026 年將成長到 14.6 億美元，到 2032 年將達到 23 億美元，複合年成長率為 7.60%。

主要市場統計數據
基準年 2025 13.7億美元
預計年份：2026年 14.6億美元
預測年份 2032 23億美元
複合年成長率 (%) 7.60%

本文全面概述了靜脈穿刺手術，重點介紹了其臨床意義、手術的複雜性以及醫療保健服務中不斷變化的營運重點。

靜脈穿刺仍然是所有醫療機構中用於診斷、治療監測和輸血服務的基本臨床操作。儘管其技術操作簡單，但實際操作卻十分複雜。正確的技術、設備的選擇以及對安全通訊協定的遵守共同決定了檢體的完整性、病患體驗和職業安全。過去十年，臨床工作的重點已從單純地提高操作成功率轉向在不同的醫療環境中整合設備安全、病患舒適度和工作流程效率。

診斷的去中心化、以安全為中心的醫療設備的創新以及採購系統的演變，正在重新定義整個醫療保健環境中的靜脈穿刺實踐。

受臨床、技術和製度等多方面因素的影響，血液採集領域正在經歷變革性的變化。在臨床方面，即時檢測和分散式醫療模式的推廣，使得血液施行地點從醫院檢查室擴展到門診診所、居家醫療機構和急診檢測場所。這種醫療服務的擴散，增加了對既要操作簡單又要保證檢體完整性和生物安全防護的設備的需求。

近期關稅和貿易政策變化對靜脈穿刺器械採購、採購韌性和供應鏈風險緩解策略的累積影響。

近期政策週期中實施的貿易政策調整和關稅措施對血液採集設備生態系統產生了累積影響，改變了採購模式和成本結構。進口醫療組件和原料的關稅相關價格上漲，導致醫院和經銷商對採購流程進行更嚴格的審查，促使供應商多元化，並對總擁有成本（TCO）進行更嚴格的評估。為此，許多相關人員優先考慮近岸外包、替代採購管道以及加強供應商契約，以降低交貨波動的影響。

基於實際細分的洞察，將應用需求、設備設計差異和各種最終用戶操作需求連結起來，以支援採購和產品策略的發展。

市場細分提供了一種系統地將臨床需求轉化為採購和產品開發優先事項的方法。根據應用領域，捐血、臨床診斷和科研領域的市場功能需求各不相同。特別是臨床診斷，它包含臨床化學、凝血、血液學、免疫學和微生物學等子領域，每個領域對檢體量、抗凝血劑相容性和周轉時間都有獨特的要求。這些應用層級的差異導致了儀器選擇的多樣性，從核心檢查室的高通量真空系統到用於緊急採血的緊湊型翼式採血器，甚至包括用於科研環境中處理小檢體或高靈敏度分析物的專用採血設備。

影響美洲、歐洲、中東和非洲以及亞太地區醫療器材採用和採購模式的區域因素。

區域趨勢正以不同的方式影響臨床環境、監管要求和供應鏈結構。在美洲，醫療保健系統呈現出多種多樣的採購模式，從集中式醫院網路到社區診所，這推動了對高通量吸痰系統和用於分散式檢查的攜帶式的需求。強調職業安全和感染控制的法律規範正在促進安全設計設備的採用和全面用戶培訓計劃的實施。

製造商、創新專家和通路合作夥伴如何協調產品演進、臨床檢驗和分銷策略，以滿足不斷變化的血液採集需求。

產業相關人員正透過優先考慮安全性、互通性和供應鏈靈活性來滿足臨床和營運需求。成熟的製造商持續投資於抽吸系統和安全注射器的分階段改進，強調與自動化分析儀的兼容性以及易於整合到檢查室工作流程中。同時，專業公司和Start-Ups則專注於差異化功能，例如符合人體工學的設計、增強的針頭安全機制以及可降低檢體吸附和溶血風險的材料。

為醫療設備製造商、醫療保健提供者和採購經理提供可操作的策略行動，以提高安全性、增強供應韌性並加速靜脈穿刺解決方案的臨床部署。

產業領導者應採取多管齊下的策略，以確保臨床意義和供應穩定性。首先，應優先考慮設備安全性和以使用者為中心的設計，投資嚴格的人體工學測試和以臨床醫生主導的改進措施。這將有助於減少工傷事故並提高檢體品質。其次，應加強供應商多元化和短期庫存規劃，以降低關稅波動和運輸風險帶來的影響。合約柔軟性和雙源採購安排可以減少外部政策衝擊的影響。

我們透過高度透明的混合調查方法確保了嚴謹的見解，該方法結合了與臨床醫生的直接互動、對工作流程的觀察分析以及有關法規和貿易的二手資訊。

本研究採用一手調查和二手調查相結合的方法，以確保研究結果的全面性和檢驗。一手調查包括對臨床實驗室經理、採血技師、採購經理和醫療設備工程師進行結構化訪談和專題討論，以了解不同環境下醫療器材應用的實際情況、挑戰和促進因素。來自臨床工作流程評估的觀察數據提供了影響器械選擇的時間和操作因素、儲存限制以及臨床環境中的交互作用等背景資訊。

簡要總結了結論，重點闡述了以安全為中心的創新、營運一致性和供應鏈韌性如何結合起來改善靜脈穿刺結果。

血液採樣仍然是一項影響深遠的臨床活動，其技術的逐步改進能夠顯著提高診斷準確性、改善患者體驗並保障醫護人員安全。無論設備類型或醫療環境如何，相關人員都已將安全至上的設計理念、與自動化臨床實驗室系統的互通性以及注重韌性的籌資策略視為優先事項。貿易政策趨勢和供應鏈壓力凸顯了靈活採購以及製造商與醫療採購方之間更緊密合作的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：靜脈穿刺術市場：依器械類型分類

  • 毛細管
  • 吸力系統
    • 玻璃
    • 塑膠
  • 注射器
    • 預填充式注射器
    • 標準注射器
  • 帶翅膀

第9章：靜脈穿刺市場：依應用領域分類

  • 捐血
  • 臨床診斷
    • 臨床化學
    • 凝血
    • 血液學
    • 免疫學
    • 微生物學
  • 研究

第10章：靜脈穿刺市場：依最終用戶分類

  • 門診治療
  • 診斷檢查室
  • 居家醫療
  • 醫院檢查室
    • 核心檢查室
    • 照護端
    • 急診檢查室

第11章：靜脈穿刺市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：靜脈穿刺市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：靜脈穿刺市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國靜脈穿刺手術市場

第15章：中國靜脈穿刺市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Greiner Bio-One International GmbH
  • Medline Industries, Inc.
  • Merck KGaA
  • Nipro Corporation
  • PH Healthcare Pvt. Ltd.
  • Parker Hannifin Corporation
  • Sarstedt AG & Co. KG
  • Sharn Inc.
  • Smiths Medical, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • TransLite LLC
  • Venoscope, LLC
  • Vygon SA
Product Code: MRR-FF012EDC38B4

The Venipuncture Procedure Market was valued at USD 1.37 billion in 2025 and is projected to grow to USD 1.46 billion in 2026, with a CAGR of 7.60%, reaching USD 2.30 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.37 billion
Estimated Year [2026] USD 1.46 billion
Forecast Year [2032] USD 2.30 billion
CAGR (%) 7.60%

A comprehensive introductory overview of venipuncture procedures highlighting clinical importance, procedural complexity, and evolving operational priorities in healthcare delivery

Venipuncture remains a foundational clinical procedure underpinning diagnostics, therapeutic monitoring, and transfusion services across healthcare settings. Its technical simplicity belies operational complexity: proper technique, device selection, and adherence to safety protocols collectively determine specimen integrity, patient experience, and occupational safety. Over the past decade, clinical priorities have shifted from exclusively optimizing procedural success rates to integrating device safety, patient comfort, and workflow efficiency across diverse points of care.

Consequently, stakeholders including clinicians, laboratory managers, procurement teams, and device manufacturers have elevated their focus on harmonizing training, standard operating procedures, and procurement criteria to reduce pre-analytical variability. This introductory overview sets the stage for a deeper examination of how technological innovation, regulatory scrutiny, and changing care delivery models are reshaping venipuncture practice. In the sections that follow, we trace these transformations and outline practical implications for clinical operations and supply-chain leadership.

How decentralization of diagnostics, safety-driven device innovation, and procurement evolution are collectively redefining venipuncture practice across care environments

The landscape surrounding venipuncture is undergoing transformative shifts driven by converging clinical, technological, and systemic forces. At the clinical front, the expansion of point-of-care testing and decentralized care models has extended venipuncture beyond hospital laboratories into ambulatory clinics, home healthcare settings, and stat testing environments. This diffusion of care has intensified demand for devices that balance ease of use with robust specimen integrity and biohazard containment.

Technological innovation has been another vector of change. Advances in evacuated systems, safety-engineered syringes, and winged sets have reduced needlestick incidents and improved sample consistency, while the move from glass to plastic components in some devices has altered handling and storage protocols. Regulatory emphasis on occupational safety standards and pre-analytical quality control is prompting manufacturers to redesign devices and provide enhanced user education. Meanwhile, procurement strategies are evolving as healthcare organizations prioritize lifecycle costs, single-use safety, and compatibility with automated processing equipment. Taken together, these shifts are redefining how venipuncture is taught, executed, and procured across care settings.

Observed cumulative effects of recent tariff and trade policy shifts on venipuncture device sourcing, procurement resilience, and supply-chain risk mitigation strategies

Trade policy adjustments and tariff measures implemented in recent policy cycles have exerted a cumulative influence on the venipuncture device ecosystem, altering sourcing patterns and cost structures. Tariff-related increases on imported medical components and raw materials have contributed to heightened procurement scrutiny among hospitals and distributors, prompting closer assessment of supplier diversification and total cost of ownership. In response, many stakeholders have prioritized nearshoring, alternative sourcing, and strengthened supplier contracts to mitigate delivery volatility.

These policy-induced pressures have also accelerated supply-chain risk management practices. Procurement teams have increased safety-stock thresholds for critical consumables and have sought contractual protections against freight and tariff variability. At the same time, clinicians and laboratory managers have had to balance cost containment with uncompromising requirements for specimen quality and staff safety. As a result, the sector has seen an uptick in collaboration between device manufacturers and institutional buyers to identify design or material substitutions that preserve clinical performance while easing tariff exposure, thereby maintaining continuity of care despite external trade headwinds.

Actionable segmentation-driven insights linking application demands, device design distinctions, and diverse end-user operational needs to inform procurement and product strategy

Segmentation provides a structured way to translate clinical needs into procurement and product development priorities. Based on application, the market's functional demands differ across blood donation, clinical diagnostics, and research. Clinical diagnostics in particular encompasses subdomains such as clinical chemistry, coagulation, hematology, immunology, and microbiology, each imposing distinct requirements for specimen volume, anticoagulant compatibility, and turnaround time. These application-level distinctions drive variations in device preference, from high-throughput evacuated systems in core laboratories to compact winged sets for stat draws and specialized collection devices used in research settings with low-volume or sensitive analytes.

Based on device type, product design and material choices meaningfully affect usability and waste management. Capillary tubes remain critical for low-volume or pediatric sampling, while evacuated systems, available in glass and plastic, serve as the backbone for routine diagnostic workflows due to their standardization and compatibility with automation. Syringes-offered as prefilled or standard configurations-address niche clinical needs where precise dosing or aspiration control is required. Winged sets continue to be favored for difficult venous access. Each device family presents specific training, storage, and sterilization considerations that influence procurement and clinical adoption.

Based on end user, the operational context dictates purchasing criteria and device selection. Ambulatory care centers and home healthcare environments prioritize compact, user-friendly devices and simplified waste handling, whereas diagnostic laboratories focus on throughput, compatibility with analyzers, and pre-analytical quality. Hospital laboratories, which include core laboratories, point-of-care testing sites, and stat laboratories, require a portfolio approach to address diverse clinical workflows and emergency demands. These segmentation lenses reveal where product innovation and service offerings will have the greatest practical impact across the care continuum.

Regional forces shaping device adoption and procurement patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific healthcare markets

Regional dynamics shape clinical practice, regulatory requirements, and supply-chain configuration in distinct ways. In the Americas, healthcare systems exhibit a wide range of procurement models from centralized hospital networks to community-based clinics, which shapes demand for both high-throughput evacuated systems and portable devices for decentralized testing. Regulatory frameworks emphasizing occupational safety and infection control have driven adoption of safety-engineered devices and comprehensive user training programs.

In Europe, Middle East & Africa, heterogeneous regulatory environments and varying healthcare infrastructure levels create opportunities for both advanced device adoption in tertiary care centers and cost-sensitive product selection in resource-constrained settings. Regional procurement collaborations and tendering mechanisms can influence device standardization, while local manufacturing capacity in certain countries supports resilience against international supply disruptions.

In Asia-Pacific, rapid expansion of diagnostic services, a growing emphasis on home and community care, and substantial investments in laboratory automation are shifting procurement toward scalable device families. The region's manufacturing base also plays a pivotal role in global supply chains, enabling quicker responses to regional demand surges but also introducing sensitivities to export controls and raw material availability. Across regions, clinical training, reimbursement policies, and institutional procurement practices remain key determinants of device uptake and lifecycle management.

How manufacturers, specialist innovators, and channel partners are aligning product evolution, clinical validation, and distribution strategies to meet shifting venipuncture demands

Industry players are responding to clinical and operational demands by prioritizing safety, interoperability, and supply-chain agility. Established manufacturers continue to invest in incremental improvements to evacuated systems and safety syringes, emphasizing compatibility with automated analyzers and ease of integration into laboratory workflows. At the same time, specialist firms and startups are focusing on differentiated features such as ergonomic designs, enhanced needle-safety mechanisms, and materials that reduce sample adsorption or hemolysis risk.

Strategic partnerships between device developers and clinical networks have increased to support real-world evaluation and iterative product enhancement. Contract manufacturing and third-party sterilization services have grown in importance as manufacturers seek to scale without heavy capital outlay. Distribution channels are evolving too, with service offerings that bundle training, waste disposal solutions, and data capture tools to support quality assurance. Competitive dynamics favor organizations that can demonstrate both clinical efficacy and operational savings through reduced needlestick injuries, streamlined workflows, and lower overall handling risk.

Practical strategic actions for device makers, healthcare providers, and procurement leaders to strengthen safety, supply resilience, and clinical uptake of venipuncture solutions

Industry leaders should adopt a multi-pronged approach to secure clinical relevance and supply resilience. First, prioritize device safety and user-centered design by investing in rigorous human factors testing and clinician-driven iterations; this will reduce occupational injuries and improve specimen quality. Second, strengthen supplier diversification and near-term inventory planning to mitigate tariff sensitivity and shipping volatility; contractual flexibility and dual-sourcing arrangements will reduce exposure to external policy shocks.

Third, enhance clinical and procurement alignment by creating cross-functional evaluation committees that weigh total cost of ownership alongside pre-analytical quality metrics. Fourth, accelerate partnerships with clinical sites for real-world evidence generation to demonstrate device performance across diverse care settings, emphasizing point-of-care and home healthcare scenarios. Fifth, invest in training and digital support tools that standardize technique and reduce variability across end users. Finally, consider modular product portfolios that allow rapid substitution of materials or components to respond to regulatory changes or supply constraints without compromising clinical performance. These actions, taken together, will enable organizations to maintain continuity of care, preserve specimen integrity, and capture emerging opportunities in decentralized diagnostics.

A transparent mixed-methods research methodology combining primary clinician engagement, observational workflow analysis, and secondary regulatory and trade sources to ensure rigorous insights

The research approach combined primary and secondary methods to ensure comprehensive, validated insights. Primary research included structured interviews and targeted discussions with clinical laboratory directors, phlebotomists, procurement managers, and device engineers to capture operational realities, pain points, and adoption drivers across settings. Observational inputs from clinical workflow assessments provided context on time-motion factors, storage constraints, and point-of-care interactions that influence device selection.

Secondary research leveraged peer-reviewed literature, clinical guidelines, and regulatory standards to ground findings in current best practices and safety requirements. Trade publications and public customs and tariff disclosures were analyzed to understand supply-chain disruptions and policy impacts. Data triangulation techniques were applied to reconcile qualitative practitioner feedback with documented standards and trade information. The methodology acknowledges limitations: respondent perspectives vary by geography and institution type, and material substitution effects depend on local regulatory acceptance. Nonetheless, the combined methods yield robust directional insights suitable for informing procurement, product development, and clinical training programs.

A concise concluding synthesis highlighting how safety-focused innovation, operational alignment, and supply resilience converge to improve venipuncture outcomes

Venipuncture remains a high-impact clinical activity where incremental improvements yield outsized benefits for diagnostic accuracy, patient experience, and staff safety. Across device types and care settings, stakeholders are converging on priorities that include safety-engineered designs, interoperability with laboratory automation, and procurement strategies that emphasize resilience. Trade policy developments and supply-chain pressures have heightened the need for flexible sourcing and closer collaboration between manufacturers and institutional buyers.

Looking ahead, organizations that align product innovation with real-world clinical workflows and that proactively manage supply-chain and regulatory risk will be best positioned to deliver value. Translating these conclusions into practical initiatives-such as targeted training programs, dual-sourcing arrangements, and clinical validation partnerships-will accelerate adoption of safer, more reliable venipuncture practices that serve both patient and system-level objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Venipuncture Procedure Market, by Device Type

  • 8.1. Capillary Tubes
  • 8.2. Evacuated Systems
    • 8.2.1. Glass
    • 8.2.2. Plastic
  • 8.3. Syringes
    • 8.3.1. Prefilled Syringes
    • 8.3.2. Standard Syringes
  • 8.4. Winged Sets

9. Venipuncture Procedure Market, by Application

  • 9.1. Blood Donation
  • 9.2. Clinical Diagnostics
    • 9.2.1. Clinical Chemistry
    • 9.2.2. Coagulation
    • 9.2.3. Hematology
    • 9.2.4. Immunology
    • 9.2.5. Microbiology
  • 9.3. Research

10. Venipuncture Procedure Market, by End User

  • 10.1. Ambulatory Care
  • 10.2. Diagnostic Laboratories
  • 10.3. Home Healthcare
  • 10.4. Hospital Laboratories
    • 10.4.1. Core Laboratories
    • 10.4.2. Point Of Care
    • 10.4.3. Stat Laboratories

11. Venipuncture Procedure Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Venipuncture Procedure Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Venipuncture Procedure Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Venipuncture Procedure Market

15. China Venipuncture Procedure Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. B. Braun Melsungen AG
  • 16.6. Becton, Dickinson and Company
  • 16.7. Cardinal Health, Inc.
  • 16.8. Greiner Bio-One International GmbH
  • 16.9. Medline Industries, Inc.
  • 16.10. Merck KGaA
  • 16.11. Nipro Corporation
  • 16.12. P. H. Healthcare Pvt. Ltd.
  • 16.13. Parker Hannifin Corporation
  • 16.14. Sarstedt AG & Co. KG
  • 16.15. Sharn Inc.
  • 16.16. Smiths Medical, Inc.
  • 16.17. Terumo Corporation
  • 16.18. Thermo Fisher Scientific Inc.
  • 16.19. TransLite LLC
  • 16.20. Venoscope, LLC
  • 16.21. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VENIPUNCTURE PROCEDURE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VENIPUNCTURE PROCEDURE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CAPILLARY TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CAPILLARY TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CAPILLARY TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STANDARD SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STANDARD SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY WINGED SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY WINGED SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY WINGED SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY BLOOD DONATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY BLOOD DONATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY BLOOD DONATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CORE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CORE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CORE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STAT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STAT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STAT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 152. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 156. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 158. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 176. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 180. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 184. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 188. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)